Cargando…
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial
Graft-versus-host disease (GvHD) assessment has been shown to be a challenge for healthcare professionals, leading to the development of the eGVHD App (www.uzleuven.be/egvhd). In this study, we formally evaluated the accuracy of using the App compared to traditional assessment methods to assess GvHD...
Autores principales: | Schoemans, Helene M., Goris, Kathy, Van Durm, Raf, Fieuws, Steffen, De Geest, Sabina, Pavletic, Steven Z., Im, Annie, Wolff, Daniel, Lee, Stephanie J., Greinix, Hildegard, Duarte, Rafael F., Poiré, Xavier, Selleslag, Dominik, Lewalle, Philippe, Kerre, Tessa, Graux, Carlos, Baron, Frédéric, Maertens, Johan A., Dobbels, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165809/ https://www.ncbi.nlm.nih.gov/pubmed/29903762 http://dx.doi.org/10.3324/haematol.2018.190777 |
Ejemplares similares
-
Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center
por: Chhabra, Prashant, et al.
Publicado: (2023) -
Chronic gvhd dictionary—eurograft cost action initiative consensus report
por: Zelić Kerep, Ana, et al.
Publicado: (2022) -
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
por: Hildebrandt, G C, et al.
Publicado: (2011) -
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation
por: Vandenhove, Benoît, et al.
Publicado: (2020) -
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
por: Servais, Sophie, et al.
Publicado: (2023)